Doxorubicin Market Revenue to Cross $1,983.40 million by 2028 to Rise at a Stellar CAGR of 6.1% by 2028 | Exclusive Research by The Insight Partners New York, July 12, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Drug Formulation,...

Rising Incidence of Cancer to Drive Doxorubicin Market at CAGR of 5.3% through 2026: Fact.MR Research United States, Rockville MD, May 04, 2022 (GLOBE NEWSWIRE) -- According to a recently published Fact.MR report, the global Doxorubicin Market is projected to grow at a compound annual rate (CAGR) of...